TREM2 INHIBITION REPROGRAMS MYELOID CELLS TO STIMULATE ANTI-TUMOR IMMUNITY THROUGH BOTH DIRECT AND INDIRECT MECHANISMS

被引:0
|
作者
Sun, Rui [1 ]
Han, Rowland [1 ]
McCornack, Colin [1 ]
Tabor, G. Travis [1 ]
Hou, Jinchao [1 ]
Cleary, Ryan [1 ]
Mao, Diane [1 ]
Liu, Qin [1 ]
Schoch, Kathleen [1 ]
Luo, Jingqin [1 ]
Petti, Allegra [2 ]
Miller, TImothy [1 ]
Ulrich, Jason [1 ]
Holtzman, David [1 ]
Kim, Albert [1 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Mass Gen Hosp, Boston, MA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IMMU-28
引用
收藏
页数:1
相关论文
共 50 条
  • [41] ANTIBODY BLOCKADE OF THE IMMUNOINHIBITORY RECEPTOR SIGLEC 10 POLARIZES TUMOR ASSOCIATED MYELOID CELLS AND PROMOTES ANTI-TUMOR IMMUNITY
    Schanin, Julia
    Luu, Thuy
    Sanchez, Robert
    Peterson, Milene
    McEwan, Lisa
    Henneberry, Evan
    Chang, Katherine
    Korver, Wouter
    Leung, John
    Youngblood, Bradford
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1451 - A1451
  • [42] JAK STAT INHIBITION REVERSES MYELOID CELL INDUCED ANTI TUMOR IMMUNITY IN T CELLS
    Ravi, Vidyha
    Neidert, Nicolas
    Will, Paulina
    Joseph, Kevin
    Hofmann, Ulrich
    Beck, Jurgen
    Schnell, Oliver
    Heiland, Dieter Henrik
    NEURO-ONCOLOGY, 2021, 23 : 208 - 208
  • [43] Inhibition of CD39 by AB598 increases extracellular ATP resulting in activation of myeloid cells and T cells to enhance anti-tumor immunity
    Jin, Ke
    Clor, Julie
    Parashar, Kaustubh
    Fuchs, Rebecca
    Stetson, L. C.
    Cho, Sean
    Walters, Matthew J.
    Fernandez-Salas, Ester
    Bowman, Christine E.
    CANCER RESEARCH, 2024, 84 (06)
  • [44] Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity
    Chen, Hui-Ming
    van der Touw, William
    Wang, Yuan Shuo
    Kang, Kyeongah
    Mai, Sunny
    Zhang, Jilu
    Alsina-Beauchamp, Dayanira
    Duty, James A.
    Mungamuri, Sathish Kumar
    Zhang, Bin
    Moran, Thomas
    Flavell, Richard
    Aaronson, Stuart
    Hu, Hong-Ming
    Arase, Hisashi
    Ramanathan, Suresh
    Flores, Raja
    Pan, Ping-Ying
    Chen, Shu-Hsia
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (12): : 5647 - 5662
  • [45] Sirt2 inhibition enhances anti-tumor immunity by promoting T cell metabolism
    Hamaidi, Imene
    Zhang, Lin
    Kim, Nayoung
    Wang, Min-Hsuan
    Iclozan, Cristina
    Fang, Bin
    Liu, Min
    Koomen, John
    Berglund, Anders
    Yoder, Sean
    Yao, Jiqiang
    Creelan, Ben
    Antonia, Scott
    Kim, Sungjune
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [46] INHIBITION OF A MAPK SIGNAL IN CANCER CELLS ENHANCED SPECIFIC ANTI-TUMOR IMMUNITY BY INCREASED PRODUCTION OF CHEMOKINES
    Iwata-Kajihara, Tomoko
    Sumimoto, Hidetoshi
    Kawamura, Naoshi
    Kawakami, Yutaka
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1042 - 1042
  • [47] SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
    Ye Wang
    Morvarid Mohseni
    Angelo Grauel
    Javier Estrada Diez
    Wei Guan
    Simon Liang
    Jiyoung Elizabeth Choi
    Minying Pu
    Dongshu Chen
    Tyler Laszewski
    Stephanie Schwartz
    Jane Gu
    Leandra Mansur
    Tyler Burks
    Lauren Brodeur
    Roberto Velazquez
    Steve Kovats
    Bhavesh Pant
    Giri Buruzula
    Emily Deng
    Julie T. Chen
    Farid Sari-Sarraf
    Christina Dornelas
    Malini Varadarajan
    Haiyan Yu
    Chen Liu
    Joanne Lim
    Huai-Xiang Hao
    Xiaomo Jiang
    Anthony Malamas
    Matthew J. LaMarche
    Felipe Correa Geyer
    Margaret McLaughlin
    Carlotta Costa
    Joel Wagner
    David Ruddy
    Pushpa Jayaraman
    Nathaniel D. Kirkpatrick
    Pu Zhang
    Oleg Iartchouk
    Kimberly Aardalen
    Viviana Cremasco
    Glenn Dranoff
    Jeffrey A. Engelman
    Serena Silver
    Hongyun Wang
    William D. Hastings
    Silvia Goldoni
    Scientific Reports, 11
  • [48] SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
    Wang, Ye
    Mohseni, Morvarid
    Grauel, Angelo
    Diez, Javier Estrada
    Guan, Wei
    Liang, Simon
    Choi, Jiyoung Elizabeth
    Pu, Minying
    Chen, Dongshu
    Laszewski, Tyler
    Schwartz, Stephanie
    Gu, Jane
    Mansur, Leandra
    Burks, Tyler
    Brodeur, Lauren
    Velazquez, Roberto
    Kovats, Steve
    Pant, Bhavesh
    Buruzula, Giri
    Deng, Emily
    Chen, Julie T.
    Sari-Sarraf, Farid
    Dornelas, Christina
    Varadarajan, Malini
    Yu, Haiyan
    Liu, Chen
    Lim, Joanne
    Hao, Huai-Xiang
    Jiang, Xiaomo
    Malamas, Anthony
    LaMarche, Matthew J.
    Geyer, Felipe Correa
    McLaughlin, Margaret
    Costa, Carlotta
    Wagner, Joel
    Ruddy, David
    Jayaraman, Pushpa
    Kirkpatrick, Nathaniel D.
    Zhang, Pu
    Iartchouk, Oleg
    Aardalen, Kimberly
    Cremasco, Viviana
    Dranoff, Glenn
    Engelman, Jeffrey A.
    Silver, Serena
    Wang, Hongyun
    Hastings, William D.
    Goldoni, Silvia
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [49] miR-130a and-145 reprogram myeloid derived suppressor cells and enhance anti-tumor immunity
    Ishii, Hiroki
    Vodnala, Suman K.
    Achyut, Bhagelu R.
    Hollander, Christine M.
    Lal, Ashish
    Yang, Li
    CANCER RESEARCH, 2017, 77
  • [50] TLR2 Signaling Promoted Tumor Development through Enhancing Inflammation and Regulatory T cells to Suppress Anti-Tumor Immunity
    Shen, Chia-Rui
    Lee, Meng-Hua
    Kuo, Ming-Ling
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):